Sestrin 2 controls the cardiovascular aging process via an integrated network of signaling pathways

Yunxia Liu1, Xiaoyu Du1, Zhehao Huang2

  • 1Cardiovascular Center, First Hospital of Jilin University, Changchun, Jilin, 130021, China.

Insights

Sestrin 2 (Sesn2) protein slows cardiovascular aging and combats age-related cardiovascular diseases through antioxidant and signaling pathway regulation. This review explores Sesn2

Area of Science:

  • Biochemistry and Molecular Biology
  • Cardiovascular Research
  • Aging and Gerontology

Background:

  • Cardiovascular aging is a primary risk factor for cardiovascular diseases (CVDs).
  • Sestrin 2 (Sesn2) is a stress-inducible protein implicated in mitigating aging processes.
  • Sesn2's role in cardiovascular health and disease is increasingly recognized.

Purpose of the Study:

  • To review the biochemical functions of Sesn2 in cardiovascular aging.
  • To describe Sesn2 expression regulation under stress.
  • To emphasize Sesn2's role in age-related CVDs and explore therapeutic potential.

Main Methods:

  • Literature review of Sesn2's biochemical functions.
  • Analysis of Sesn2 regulation under stress conditions.
  • Examination of Sesn2 signaling in age-related cardiovascular diseases.

Main Results:

  • Sesn2 exhibits antioxidant activity and regulates antioxidant pathways.
  • Sesn2 activates adenosine monophosphate-activated protein kinase (AMPK) and inhibits mTORC1.
  • Sesn2 signaling is linked to hypertension, ischemia-reperfusion injury, atherosclerosis, and heart failure.

Conclusions:

  • Sesn2 acts as a crucial anti-aging agent in the cardiovascular system.
  • Sesn2 plays a significant role in the pathophysiology of various age-related CVDs.
  • Targeting Sesn2 presents promising therapeutic strategies for cardiovascular aging and disease.

Related Concept Videos

Regulation of the Cardiovascular System01:27

Regulation of the Cardiovascular System

The regulation of the cardiovascular system allows the body to adapt to various demands and maintain homeostasis.
The regulation of the cardiovascular system involves the autonomic nervous system (ANS), baroreceptors, and chemoreceptors, ensuring that heart rate and blood pressure are appropriately modulated in response to varying physiological demands.
The ANS comprises two main divisions: the sympathetic and parasympathetic nervous systems. The sympathetic nervous system enhances...
3.3K
Nitric Oxide Signaling Pathway01:28

Nitric Oxide Signaling Pathway

Nitric oxide (NO), an inorganic gas, acts as a potent second messenger in most animal and plant tissues. NO diffuses out of the cells that produce it and enters the neighboring cells to generate a downstream response. NO synthase (NOS) catalyzes NO production by the deamination of the amino acid arginine. There are three isoforms of NOS. Endothelial cells have endothelial NOS (eNOS), nerve and muscle cells have neuronal NOS (nNOS), and macrophages produce inducible NOS (iNOS) upon exposure...
6.0K
Hormonal Regulation of Blood Pressure01:17

Hormonal Regulation of Blood Pressure

Endocrinal or hormonal intervention in the cardiovascular system is predominantly exerted by the catecholamines - epinephrine and norepinephrine, as well as a slew of hormones that interact with renal function to modulate blood volume.
Epinephrine and Norepinephrine
The adrenal medulla releases epinephrine and norepinephrine, catecholamines that enhance and extend the sympathetic or "fight or flight" physiological response. These hormones escalate heart rate and the force of contraction...
5.6K
Regulation of Heart Rates01:31

Regulation of Heart Rates

The regulation of heart rate is a complex process controlled by the autonomic nervous system (ANS), hormonal influences, and intrinsic cardiac mechanisms. The ANS has two main components: the sympathetic nervous system (SNS) and the parasympathetic nervous system (PNS).
The SNS increases heart rate through the release of norepinephrine and epinephrine, which act on beta-1 adrenergic receptors in the heart. This action increases the rate of depolarization in the sinoatrial (SA) node, the heart's...
3.5K
Hypertension II: Pathophysiology01:29

Hypertension II: Pathophysiology

Hypertension is a chronic condition in which the blood's force against artery walls is excessively high, posing risks such as heart disease. The condition's underlying mechanisms involve complex interactions among the cardiovascular, kidney, and autonomic nervous systems.Renin-Angiotensin-Aldosterone System (RAAS): This system significantly influences blood pressure regulation. When blood pressure decreases, the kidneys secrete renin. This enzyme transforms angiotensinogen, a plasma protein,...
599
Regulation of Angiogenesis and Blood Supply01:24

Regulation of Angiogenesis and Blood Supply

Rapidly dividing tumors, embryos, and wounded tissues require more oxygen than usual, lowering the oxygen concentration in the blood. At low oxygen or hypoxic conditions, an oxygen-sensitive transcription factor called the hypoxia-inducible factor 1 or HIF1 is activated. HIF1 is a dimeric protein of alpha (ɑ) and beta (β) subunits.  Under optimal oxygen conditions, HIF1β is present in the nucleus while HIF1ɑ remains in the cytosol. HIF1ɑ is hydroxylated by prolyl...
3.2K